Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Galletly

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Translational Psychiatry|August 9, 2017
Brain antibodies in the cortex and blood of people with schizophrenia and controlsL J Glass, D Sinclair, D Boerrigter, et al.
Molecular Psychiatry|May 19, 2015
Adjunctive raloxifene treatment improves attention and memory in men and women with schizophreniaT W Weickert, D Weinberg, R Lenroot, et al.
Psychological Medicine|December 25, 2013
Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosisV A Morgan, J J McGrath, A Jablensky, et al.
Molecular Psychiatry|September 9, 2015
A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samplesO S Cohen, T W Weickert, J L Hess, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Translational Psychiatry|August 9, 2017
Brain antibodies in the cortex and blood of people with schizophrenia and controlsL J Glass, D Sinclair, D Boerrigter, et al.
Molecular Psychiatry|May 19, 2015
Adjunctive raloxifene treatment improves attention and memory in men and women with schizophreniaT W Weickert, D Weinberg, R Lenroot, et al.
Psychological Medicine|December 25, 2013
Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosisV A Morgan, J J McGrath, A Jablensky, et al.
Molecular Psychiatry|September 9, 2015
A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samplesO S Cohen, T W Weickert, J L Hess, et al.
Pageof 13